SIGNAPRED 16 Tablet is a high-strength corticosteroid formulation containing Methylprednisolone 16 mg, designed for effective treatment of severe inflammatory, allergic, and autoimmune conditions. Manufactured by Bluepill Express in internationally certified facilities, it offers consistent potency and safety for global pharmaceutical markets.

This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

SIGNAPRED 16 Tablet is a potent corticosteroid medication that contains Methylprednisolone 16 mg, a synthetic glucocorticoid with powerful anti-inflammatory and immunosuppressive properties. It is indicated for the management of a wide range of chronic and acute disorders where inflammation plays a central role, and where higher doses of corticosteroids are clinically warranted.

Methylprednisolone works by modulating the body’s immune response and suppressing the production of inflammatory mediators such as cytokines, prostaglandins, and interleukins. This mechanism provides rapid relief from symptoms such as swelling, redness, pain, and immune system overactivity. SIGNAPRED 16 is widely used in the treatment of conditions including severe asthma, rheumatoid arthritis, lupus erythematosus, allergic reactions, multiple sclerosis exacerbations, ulcerative colitis, psoriasis, and certain types of cancers as part of chemotherapy regimens.

Bluepill Express, a globally recognized third-party pharmaceutical manufacturer, formulates SIGNAPRED 16 Tablet in WHO-GMP, ISO, and DCGI-approved facilities. The company adheres to strict international guidelines to ensure high-quality production, offering superior stability, uniform dosage strength, and precise pharmacokinetics. The formulation is ideal for long-term and short-term corticosteroid therapy, based on clinical requirements.

The product is manufactured with high-grade active pharmaceutical ingredients and excipients, which are carefully selected to maintain purity, stability, and efficacy. Each batch of SIGNAPRED 16 undergoes stringent in-process and post-production quality checks, including content uniformity, dissolution, microbial limits, and packaging integrity.

SIGNAPRED 16 is supplied in an easy-to-administer oral tablet form, offering convenience for patients in both outpatient and inpatient care settings. The robust packaging is moisture-resistant and tamper-evident, meeting international export requirements for pharmaceutical goods. The product is suitable for private-label branding, institutional sales, tenders, and hospital distribution.

With Bluepill Express as the third-party manufacturer, pharmaceutical distributors and marketing companies benefit from full regulatory support, including Certificate of Analysis (COA), Certificate of Pharmaceutical Product (COPP), stability studies, CTD dossiers, and country-specific export documentation. The company also offers customization in packaging design, language labeling, and branding to suit various international markets including Latin America, Southeast Asia, Africa, and the Middle East.

SIGNAPRED 16 should be used under strict medical supervision due to the potential for side effects, especially with prolonged use. These may include Cushingoid symptoms, adrenal suppression, glucose intolerance, and increased susceptibility to infection. Comprehensive product leaflets and prescribing information are provided to ensure safe and informed usage.